Tenaya Therapeutics Inc Forecast, price target & analysts
Tenaya Therapeutics Inc Target price 2026 - Analyst rating & recommendation
Tenaya Therapeutics Inc Classifications & Recommendation
Tenaya Therapeutics Inc Price Target
| Target Price | $3.57 |
| Price | $0.62 |
| Potential |
475.81%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Tenaya Therapeutics Inc 2027 .
The average Tenaya Therapeutics Inc target price is $3.57.
This is
475.81%
register free of charge
$42.00
6,674.19%
register free of charge
$2.02
225.81%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend Tenaya Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tenaya Therapeutics Inc stock has an average upside potential 2027 of
475.81%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 4.07 |
7 Analysts have issued a sales forecast Tenaya Therapeutics Inc 2026 . The average Tenaya Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Tenaya Therapeutics Inc EBITDA forecast 2026. The average Tenaya Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Tenaya Therapeutics Inc Analysts have issued a net profit forecast 2026. The average Tenaya Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.59 | -0.50 |
| 54.96% | 15.25% | |
| P/E | negative | |
| EV/Sales | 14.96 |
9 Analysts have issued a Tenaya Therapeutics Inc forecast for earnings per share. The average Tenaya Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Tenaya Therapeutics Inc...
Current Tenaya Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Chardan Capital |
Locked
➜
Locked
|
Locked | Mar 12 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 02 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Mar 12 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 02 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 27 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
